
Sign up to save your podcasts
Or


Radiopharm Theranostics: The tip of the spear in cancer fighting technologies!
Listen to ASX-listed Radiopharm Theranostics Exec Chairman Paul Hopper talk to Matt Birney on the Bulls N’ Bears Report about Radiopharm’s $150m ASX listing that will develop a range of cancer fighting technologies based on “radiopharmaceuticals”.
See omnystudio.com/listener for privacy information.
By Bulls N' Bears on 6PR RadioRadiopharm Theranostics: The tip of the spear in cancer fighting technologies!
Listen to ASX-listed Radiopharm Theranostics Exec Chairman Paul Hopper talk to Matt Birney on the Bulls N’ Bears Report about Radiopharm’s $150m ASX listing that will develop a range of cancer fighting technologies based on “radiopharmaceuticals”.
See omnystudio.com/listener for privacy information.

52 Listeners

23 Listeners

65 Listeners

29 Listeners

22 Listeners

2 Listeners

4 Listeners

5 Listeners

2 Listeners

9 Listeners